{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:46:23Z","timestamp":1792683983303,"version":"4.5.0"},"reference-count":11,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,16]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Persistent migraine aura without infarction is a rare but debilitating condition. Treatment options are mostly anecdotal and limited due to inefficacy and side effects. We present a 16-year-old female patient with triple X syndrome, having persistent aura symptoms for over 2 years, consisting of continuous visual and sensory sensations. Previous treatments with seven different migraine preventatives were not successful. The patient successfully responded to zonisamide against refractory prolonged aura and remained symptom-free under the ongoing treatment without any relevant side effects. Zonisamide may be considered a new and safe treatment option for patients with persistent migraine aura.<\/jats:p>","DOI":"10.1136\/bcr-2020-240783","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T11:49:51Z","timestamp":1618228191000},"page":"e240783","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Zonisamide as treatment option in persistent migraine aura"],"prefix":"10.1136","volume":"14","author":[{"given":"Katharina","family":"Kaltseis","sequence":"first","affiliation":[{"name":"Neurology, Innsbruck Medical University Department of Neurology, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Frank","sequence":"additional","affiliation":[{"name":"Neurology, Innsbruck Medical University Department of Neurology, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Broessner","sequence":"additional","affiliation":[{"name":"Neurology, Innsbruck Medical University Department of Neurology, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"2025082708180500000_14.4.e240783.1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"2025082708180500000_14.4.e240783.2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/head.12879","article-title":"Rare complications of migraine with aura","volume":"56","author":"Plato","year":"2016","journal-title":"Headache"},{"key":"2025082708180500000_14.4.e240783.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.1.261"},{"key":"2025082708180500000_14.4.e240783.4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.01150.x"},{"key":"2025082708180500000_14.4.e240783.5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.5.732"},{"key":"2025082708180500000_14.4.e240783.6","doi-asserted-by":"publisher","DOI":"10.1111\/head.12392"},{"key":"2025082708180500000_14.4.e240783.7","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-019-0558-1","article-title":"Current status of antiepileptic drugs as preventive migraine therapy","volume":"21","author":"Parikh","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"2025082708180500000_14.4.e240783.8","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e318225140c"},{"key":"2025082708180500000_14.4.e240783.9","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e318170577f"},{"key":"2025082708180500000_14.4.e240783.10","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.23768","article-title":"Comparing zonisamide with sodium valproate in the management of migraine headaches: double-blind randomized clinical trial of efficacy and safety","volume":"18","author":"Assarzadegan","year":"2016","journal-title":"Iran Red Crescent Med J"},{"key":"2025082708180500000_14.4.e240783.11","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2009.109"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-240783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:18:13Z","timestamp":1756307893000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-240783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":11,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,12]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-240783"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-240783","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}